Sovereign Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Buy
257
+15
+6% +$15.3K 0.06% 82
2026
Q1
$223K Buy
+242
New +$245K 0.05% 94
2025
Q1
Sell
-284
Closed -$219K 69
2024
Q4
$219K Buy
+284
New +$235K 0.07% 89

Other funds holding LLY

Sovereign Investment Advisors's LLY Position: Q2 2026 in Review

Sovereign Investment Advisors increased its Eli Lilly (LLY) stake by 6.2% in Q2 2026, buying an estimated $15.3K and bringing the position to 257 shares worth $308K. The position accounts for 0.06% of the portfolio, ranked #82.

Sovereign Investment Advisors first reported a position in LLY in Q4 2024 and has held it in 3 quarters since. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sovereign Investment Advisors held 257 shares of Eli Lilly worth $308K as of Q2 2026.
  • Sovereign Investment Advisors bought 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.06% of Sovereign Investment Advisors's portfolio in Q2 2026, its #82 holding.
  • Sovereign Investment Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 3 quarters since.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sovereign Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.